Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hematologic Neoplasms 4Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Lung Neoplasms 1Hypogonadism 1Hematopoietic and Lymphatic System Neoplasm 1Heart Failure 1Colitis 1Central Nervous System Neoplasms 1Cardiomyopathies 1Carcinoma, Non-Small-Cell Lung 1Anemia, Aplastic 1

Interventions

Fecal Microbiota Transplantation 2vedolizumab 1prednylidene 1niraparib 1motexafin gadolinium 1gallium 68 PSMA-11 1fludarabine 1deltacortene 1darolutamide 1cabozantinib 1atezolizumab 1apalutamide 1aldesleukin 1Sunitinib 1Standard of Care 1Specimen Handling 1Sildenafil Citrate 1Radiosurgery 1Prednisone 1Practice Guidelines as Topic 1Nivolumab 1Magnetic Resonance Spectroscopy 1Loperamide 1LDP-02 1Ipilimumab 1Interleukin-2 1Infliximab 1Immunoglobulin G 1Genetic Testing 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Urogenital Neoplasms × Practice Guidelines as Topic × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡